These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 21498462)

  • 41. Autochthonous experience, heightened awareness, and perception distortion in patients with schizophrenia: a symptomatological study.
    Honda T; Suzuki H; Iwai K; Fujiwara Y; Kawahara H; Kuroda S
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):473-9. PubMed ID: 15482577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients.
    Brucato G; First MB; Dishy GA; Samuel SS; Xu Q; Wall MM; Small SA; Masucci MD; Lieberman JA; Girgis RR
    Psychol Med; 2021 Jan; 51(1):112-120. PubMed ID: 31658912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis.
    Dazzan P; Soulsby B; Mechelli A; Wood SJ; Velakoulis D; Phillips LJ; Yung AR; Chitnis X; Lin A; Murray RM; McGorry PD; McGuire PK; Pantelis C
    Schizophr Bull; 2012 Sep; 38(5):1083-91. PubMed ID: 21518921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].
    Demily C; Jacquet P; Marie-Cardine M
    Encephale; 2009 Apr; 35(2):139-45. PubMed ID: 19393382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The course of anhedonia during 10 years of schizophrenic illness.
    Herbener ES; Harrow M
    J Abnorm Psychol; 2002 May; 111(2):237-48. PubMed ID: 12003446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conceptualizing schizophrenia through attenuated symptoms in the population.
    Carpenter WT
    Am J Psychiatry; 2010 Sep; 167(9):1013-6. PubMed ID: 20826849
    [No Abstract]   [Full Text] [Related]  

  • 48. The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology.
    Erlenmeyer-Kimling L; Cornblatt BA; Rock D; Roberts S; Bell M; West A
    Schizophr Bull; 1993; 19(1):141-53. PubMed ID: 8451608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gender, psychopathology, and development: from puberty to early adulthood.
    Galdos P; van Os J
    Schizophr Res; 1995 Jan; 14(2):105-12. PubMed ID: 7710990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three syndromes in schizophrenia: validity in young patients with recent onset of illness.
    Gureje O; Aderibigbe YA; Obikoya O
    Psychol Med; 1995 Jul; 25(4):715-25. PubMed ID: 7480449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
    John JP; Khanna S; Thennarasu K; Reddy S
    Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positive and negative symptoms in the psychoses. Re-analysis of published SAPS and SANS global ratings.
    Klimidis S; Stuart GW; Minas IH; Copolov DL; Singh BS
    Schizophr Res; 1993 Mar; 9(1):11-8. PubMed ID: 8461266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between positive symptoms and instrumental work functioning in schizophrenia: a 10 year follow-up study.
    Racenstein JM; Harrow M; Reed R; Martin E; Herbener E; Penn DL
    Schizophr Res; 2002 Jul; 56(1-2):95-103. PubMed ID: 12084424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The significance of at-risk symptoms for psychosis in children and adolescents.
    Schimmelmann BG; Walger P; Schultze-Lutter F
    Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Momentary assessment research in psychosis.
    Oorschot M; Kwapil T; Delespaul P; Myin-Germeys I
    Psychol Assess; 2009 Dec; 21(4):498-505. PubMed ID: 19947784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reliability of measuring anomalous experience: the Bonn Scale for the Assessment of Basic Symptoms.
    Vollmer-Larsen A; Handest P; Parnas J
    Psychopathology; 2007; 40(5):345-8. PubMed ID: 17657133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive and negative symptoms in neuroleptic-free psychotic inpatients.
    Stuart GW; Malone V; Currie J; Klimidis S; Minas IH
    Schizophr Res; 1995 Aug; 16(3):175-88. PubMed ID: 7488563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emotional processing in a non-clinical psychosis-prone sample.
    van 't Wout M; Aleman A; Kessels RP; Larøi F; Kahn RS
    Schizophr Res; 2004 Jun; 68(2-3):271-81. PubMed ID: 15099609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New diagnostic criteria of deficits in schizophrenia by the Carpenter school: importance and validity].
    Ribeyre JM; Lesieur P; Varoquaux O; Dollfus S; Petit M
    Ann Med Psychol (Paris); 1993 Apr; 151(4):316-20; discussion 320-1. PubMed ID: 8285500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.